Back to Authors

Kantarci, Orhun H.

https://orcid.org/0000-0001-7038-8133

Mayo Clinic

Mayo Clinic

Citations 143

Clinical Reasoning: A 73-year-old man with sarcoidosis and multifocal ischemic strokes
Pichler, Michael, Klaas, James P. , Temesgen, Zelalem , Kantarci, Orhun H. , Klaas, James

Neurology | September 19, 2016 | Volume: 87 | Issue: 12 | Pages: No page available

10.1212/wnl.0000000000003128 Get It

A new dawn for genetic association studies in multiple sclerosis
Kantarci, Orhun H.

Neurology Genetics | August 5, 2016 | Volume: 2 | Issue: 4 | Pages: No page available

10.1212/nxg.0000000000000093 Get It

Infliximab is a plausible alternative for neurologic complications of Behçet disease
Zeydan, Burcu , Saip, Sabahattin , Demirci, Onat , Hamuryudan, Vedat , Sıva, Aksel , Kantarci, Orhun H. , Uygunoğlu, Uğur , Demirci, Onat N, Seyahi, Emire, Uğurlu, Serdal , Seyahi, Emire , Siva, Aksel , Zeydan, Burcu

Neurology Neuroimmunology & Neuroinflammation | July 12, 2016 | Volume: 3 | Issue: 5 | Pages: No page available

10.1212/nxi.0000000000000258 Get It

Integrated multidisciplinary clinics should be the gold standard in managing progressive MS – YES
Uygunoğlu, Uğur , Kantarci, Orhun H. , Sıva, Aksel , Siva, Aksel

Multiple Sclerosis Journal | May 25, 2016 | Volume: 22 | Issue: 9 | Pages: 1126-1128

10.1177/1352458516650526 Get It

The cerebellar channelopathy of multiple sclerosis
Waxman, Stephen G. , Kantarci, Orhun H.

Neurology | January 7, 2016 | Volume: 86 | Issue: 5 | Pages: 406-407

10.1212/wnl.0000000000002338 Get It

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome
Kantarci, Orhun H. , Lebrun‐Frénay, Christine , Sıva, Aksel , Keegan, Mark B., Azevedo, Christina , Inglese, Matilde , Tintoré, Mar , Newton, Braeden D. , Amato, Maria Pia , Stefano, Nicola De , Sormani, Maria Pia , Pelletier, Daniel, Okuda, Darin T. , Lebrun‐Frénay, Christine , Durand‐Dubief, Françoise , Tintoré, Mar , Sormani, Maria P , Amato, Maria Pia , Siva, Aksel , Okuda, Darin T

Annals of Neurology | November 25, 2015 | Volume: 79 | Issue: 2 | Pages: 288-294

10.1002/ana.24564 Get It

ObjectiveThe aim of this work was to evaluate the preprogressive phase in subjects with radiologically isolated syndrome (RIS) who evolve to primary progressive multiple sclerosis (PPMS).MethodsA multicenter RIS cohort was previously established. Demographic, clinical, and radiological characteristics of subjects with RIS that evolved directly to PPMS were compared to those that developed a relapsing disease course from onset (clinically isolated syndrome [CIS] or relapsing‐remitting MS) and were also compared to two other population‐ and clinic‐based PPMS cohorts.ResultsOf the 453 subjects with RIS, 128 evolved to symptomatic MS during the follow‐up (113 developed a first acute clinical event consistent with CIS/MS, 15 evolved to PPMS). PPMS prevalence (11.7%) and onset age (mean ± standard deviation; 49.1 ± 12.1) in the RIS group were comparable to other PPMS populations (p > 0.05). Median time to PPMS was 3.5 years (range, 1.6–5.4). RIS evolved to PPMS more commonly in men (p = 0.005) and at an older age (p < 0.001) when compared to CIS/MS, independent of follow‐up duration. Subjects who evolved to PPMS had more spinal cord lesions (100%) before symptomatic evolution than those that developed CIS/MS (64%) and those that remained asymptomatic (23%) within the follow‐up period (P = 0.005). Other MRI characteristics in the preprogressive phase of PPMS were indistinguishable from CIS/MS.InterpretationSubjects with RIS evolve to PPMS at the same frequency as expected from general MS populations in an age‐dependent manner. Besides age, unequivocal presence of spinal cord lesions and being male predicted evolution to PPMS. Our findings further suggest that RIS is biologically part of the MS spectrum. Ann Neurol 2016;79:288–294